LOSCALZO JOSEPH
SEC Form 4 insider trading activity
LOSCALZO JOSEPH has filed 5 SEC Form 4 filings (18 transaction rows) across 2 companies, including IONS, CYPH, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: May 6, 2026.
On the most recent filing, LOSCALZO JOSEPH is listed as Director at IONIS PHARMACEUTICALS INC. Inside the rolling window, LOSCALZO JOSEPH reported no open-market purchases and 4 open-market sales totaling $7.1M in IONS. The largest disclosed transaction in the window is a sale of 77,289 IONS shares on May 4, 2026, worth $5.8M.
Companies traded
Other insiders at IONS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.1M
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 3, 2025 | IONS | Sale | $962K |
Frequently asked questions
How many SEC Form 4 filings has LOSCALZO JOSEPH made?
LOSCALZO JOSEPH has filed 5 SEC Form 4 filings (18 transaction rows) across 2 companies, including IONS, CYPH since 2025.
Which companies does LOSCALZO JOSEPH trade?
LOSCALZO JOSEPH has filed SEC Form 4 disclosures for 2 companies, including IONS, CYPH.
When was LOSCALZO JOSEPH's most recent SEC Form 4 filing?
LOSCALZO JOSEPH's most recent SEC Form 4 filing on Tracefour is dated May 6, 2026.
What is LOSCALZO JOSEPH's total buy and sell value in the current window?
Inside the rolling retention window, LOSCALZO JOSEPH bought $0 and sold $7.1M based on SEC Form 4 filings.
What was LOSCALZO JOSEPH's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 77,289 IONS shares on 2026-05-04, worth $5.8M, per SEC Form 4 filings.